title: Successful Afatinib Therapy after Resistance to EGFR-TKI in a Patient with Advanced Adenosquamous Cell Lung Cancer.
authors.affiliation: Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba, Mito, Japan.
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Tamura
authors.forename: Katsunori
authors.initials: K
authors.lastname: Kagohashi
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Satoh
mesh_terms: D000077716:Afatinib; D000368:Aged; D018196:Carcinoma, Adenosquamous / Q000188:drug therapy*; D019008:Drug Resistance, Neoplasm; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000235:genetics; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D009154:Mutation; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011799:Quinazolines / Q000627:therapeutic use*
chemical_list: D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000077716:Afatinib; D066246:ErbB Receptors